|
Among patients with NYHA class II or III heart failure, a wide QRS complex, and left ventricular systolic dysfunction, the addition of CRT to an ICD reduced rates of death and hospitalization for heart failure. ...
|
|
TRUST is the first and largest clinical trial to demonstrate the safety and efficacy of daily remote monitoring with BIOTRONIK Home Monitoring. This multi-center, prospective, randomized trial enrolled 1,450 pati ...
|
|
The COMPAS trial is the first & only large-scale pacemaker patient study to demonstrate that daily automatic remote monitoring with BIOTRONIK Home Monitoring® is safe and effective in the long-term and significan ...
|
|
The EchoCRT landmark trial evaluates the effects of Cardiac Resynchronization Therapy (CRT) on mortality and morbidity in patients with advanced heart failure.
|
|
BIOTRONIK’s AlCath® Gold Ablation Catheter outperforms platinum-iridium tips for typical atrial flutter ablation.
|
|
Congress Contents |
Education |
Abstracts |
Registration |
Exhibits |
Practical Information |
Final Program
Click here to read it